Health & Science

Epidemiologists say governments need to do more than just order people not to see friends and family.

There’s now a “repair or demolish” order on the Rodeway Inn, which is in a historic Center City property.

Health system officials in Pennsylvania, Delaware and New Jersey describe conditions on the ground now, and how they compare to the spring’s first wave.

The U.S. added more than 1 million cases in the past week. More than 85,000 people are hospitalized. Some states may have no choice but to lock down again.

Philadelphia Health Commissioner Thomas Farley said, unchecked, the rising infection and fatality rates could strain hospital resources.

The Strategic National Stockpile stores critical supplies. It fell short when the pandemic began. A new effort is underway, but it's still not providing what the U.S. needs.

The decision to move forward with indoor gatherings and project a sense of normalcy comes as health experts have been pleading with Americans to cut back on Thanksgiving.

Governors and mayors are ratcheting up mask mandates and imposing restrictions on small indoor gatherings, which have been blamed for accelerating the spread of COVID-19.

Despite emphatic warnings from public health authorities to stay home for Thanksgiving, millions of Americans are crowding the nation’s airports ahead of the holiday.

With little concrete information, the city health department is trying to work out logistics.

Pharmaceutical company AstraZeneca made the announcement on Monday, saying that one dosing regimen showed the drug was 90% effective in preventing infection.

Deciding to gather or not can seem like just one more thing to deal with in this pandemic-disrupted year.

The experimental cocktail from the bio-tech company Regeneron is the same drug President Trump got when he was battling the coronavirus earlier this year.

Which test should you go for? Can you even schedule one? How long should you isolate before your test, and afterward? There’s a lot to consider.

PBS Newshour's John Yang reflects on his experience participating in Moderna's vaccine trial. "It started off with self-interest — I wanted to get the vaccine sooner."